Bibliographic Info
GuidelineAntiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach 2010 revision
Year of Publication2010
Issuing InstitutionWHO
Recommendation
Status
Updated
Recommended in favor
Conditional
Certainty of evidence
Very low
For children >3 years of age with TB, the preferred regimen is efavirenz (EFV) + 2 nucleoside reverse transcriptase inhibitor (NRTI)